Anupam Rasayan India has demonstrated strong top-line growth in its third-quarter results for the 2025-26 fiscal year, reported on February 14, 2026. The specialty chemicals manufacturer saw total revenue jump by 31.35% to 512.44 crore, compared to 390.14 crore in the same period last year. Profitability remained on an upward trajectory with a 12% increase in consolidated net profit, reaching 61 crore. The company's standalone performance was notably stronger, with net profit surging 150% to 47.9 crore. For the nine-month period ending December 2025, consolidated revenue grew by 84% to 1,744.5 crore. Despite the revenue surge, operating margins faced pressure from rising expenses, which climbed to 454.59 crore during the quarter. EBITDA margins stood at 24.9%, reflecting a shift toward higher sales volumes amidst a complex global cost environment. A transformative milestone for the company is the definitive agreement to acquire 100% of US-based Jayhawk Fine Chemicals for 150 million dollars. This strategic move establishes a direct manufacturing presence in North America and integrates Jayhawk’s expertise in high-purity technologies and Suzuki Coupling with Anupam’s cost-efficient India-based manufacturing. The acquisition is being financed through 50 million dollars in new credit facilities and internal accruals. It is expected to be immediately earnings-accretive, opening doors to high-value markets including semiconductors, automotive electronics, and advanced pharmaceuticals. In the equity markets, Anupam Rasayan shares closed at 1,335.70 on February 13, 2026. The stock has delivered exceptional returns over the past year, rising approximately 93% and significantly outperforming the broader benchmark indices. The Indian specialty chemicals sector continues to evolve from volume-based growth to value-oriented innovation. Companies are increasingly focusing on custom synthesis and sustainable chemistry to meet rising demand in the electric vehicle, digital infrastructure, and healthcare segments. With a robust order book and newly signed contracts valued at 14,646 crore, Anupam Rasayan is positioned to leverage its expanded global footprint. The integration of US operations is set to provide a dual-site manufacturing model, offering global customers greater supply chain flexibility and localized production capabilities.